Advertisement
Screener

Pluri Inc. (PLUR) Form D

Pluri Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2025-03-19: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-02-03; Total offering amount $3,500,000.
  • 2022-12-30: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2022-12-13; Total offering amount $8,469,323.
  • 2010-10-14: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale 2010-10-12; Total offering amount $1,220,003.
  • 2010-05-11: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; Date of first sale 2010-04-26; Total offering amount $250,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2025-03-19Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2025-02-03$3,500,000$3,500,000$01
2022-12-30Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2022-12-13$8,469,323$8,469,323$014
2010-10-14Rule 506Equity; OptionToAcquire2010-10-12$1,220,003$1,220,003$09
2010-05-11Rule 506Equity; OptionToAcquire2010-04-26$250,000$250,000$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Passage BIO, Inc. (PASG)United States$0.015B-0.43
IN8BIO, INC. (INAB)United States$0.012B-0.76
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B